BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 349171)

  • 21. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity of N-methyl-N'-aryl-N-nitrosoureas and N-methyl-N'-aryl-N'-methyl-N-nitrosoureas in relation to their alkylating activity.
    Yano K; Isobe M
    Cancer Res; 1979 Dec; 39(12):5147-9. PubMed ID: 387220
    [No Abstract]   [Full Text] [Related]  

  • 23. Comutagenic effects exerted by N-nitroso compounds.
    Guttenplan JB
    Mutat Res; 1979 Jan; 66(1):25-32. PubMed ID: 370583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrosourea interaction with chromatin and effect on poly(adenosine diphosphate ribose) polymerase activity.
    Sudhakar S; Tew KD; Schein PS; Woolley PV; Smulson ME
    Cancer Res; 1979 Apr; 39(4):1411-7. PubMed ID: 217535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
    Kohlhepp SJ; May HE; Reed DJ
    Drug Metab Dispos; 1981; 9(2):135-41. PubMed ID: 6113112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of the mutagenicities of N-methyl-N'-nitro-N-nitrosoguanidine and N-methyl-N-nitrosourea by glucose.
    Shirai A; Umezawa K; Matsushima T; Sugimura T
    Mutat Res; 1980 Aug; 72(1):73-7. PubMed ID: 7003366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies on the mutagenicity of 1,1'-ethylene-bis-(1-nitrosourea) and related compounds in Escherichia coli in relation to the formation of DNA interstrand cross-links.
    Morimoto K; Yoshikawa K; Yamaha T
    Gan; 1980 Oct; 71(5):674-8. PubMed ID: 7014343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective monooxygenation of carcinostatic 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by purified cytochrome P-450 isozymes.
    Potter DW; Levin W; Ryan DE; Thomas PE; Reed DJ
    Biochem Pharmacol; 1984 Feb; 33(4):609-13. PubMed ID: 6704177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas.
    Kohn KW
    Cancer Res; 1977 May; 37(5):1450-4. PubMed ID: 851960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential sensitivity of colony-forming cells of hemopoietic tissue, Lewis lung carcinoma, and B16 melanoma to three nitrosoureas.
    Blackett NM; Courtenay VD; Mayer SM
    Cancer Chemother Rep; 1975; 59(5):929-33. PubMed ID: 1203897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential repair of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea-induced DNA damage in two human colon tumor cell lines.
    Erickson LC; Osieka R; Kohn KW
    Cancer Res; 1978 Mar; 38(3):802-8. PubMed ID: 626984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.
    Brajtburg J; Elberg S; Kobayashi GS; Medoff G
    Antimicrob Agents Chemother; 1988 Mar; 32(3):327-30. PubMed ID: 3284460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
    Kukushkina GV; Peretolchina NM; Minenkova EA; VerovskiÄ­ VN; Sof'ina ZP
    Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of mechanism of action studies of the nitrosoureas.
    Bono VH
    Cancer Treat Rep; 1976 Jun; 60(6):699-702. PubMed ID: 182364
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of biochemical and biological effects of four nitrosoureas with differing carbamoylating activities.
    Kann HE
    Cancer Res; 1978 Aug; 38(8):2363-6. PubMed ID: 149589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.
    Drewinko B; Loo TL; Gottlieb JA
    Cancer Res; 1976 Feb; 36(2 Pt 1):511-5. PubMed ID: 1260749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increases in protein A24 following treatment of Ehrlich ascites tumor cells with 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Dornish JM; Smith-Kielland I
    FEBS Lett; 1981 Dec; 136(1):41-4. PubMed ID: 6274701
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms of synergism in the mutagenicity of cadmium and N-methyl-N-nitrosourea in Salmonella typhimurium: the effect of pH.
    Mandel R; Ryser HJ
    Mutat Res; 1987 Jan; 176(1):1-10. PubMed ID: 3540647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differences in the mutagenic effectiveness of N-nitrosomethyl- and N-nitrosoethylurea acting on bacterial DNA in vivo].
    Vasil'eva SV
    Genetika; 1976; 12(5):149-56. PubMed ID: 789181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of DNA lesions produced by tumor-inhibitory 1,2-bis(sulfonyl)hydrazines and chloroethylnitrosoureas.
    Penketh PG; Shyam K; Sartorelli AC
    Biochem Pharmacol; 2000 Feb; 59(3):283-91. PubMed ID: 10609557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.